CIK: 1749623 - Address: C/O Newamsterdam Pharma Company N.V., Gooimeer 2-35, Naarden, P7 1411 DC
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
12/16/24 06:00
12/12/24
APGEApogee Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagMcKenna Mark C.MADP99149.54020New20D
6/2/23 19:13
6/2/23
RXDXPrometheus Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsMcKenna Mark C.CADOCB,P,CEOM.d3552.900123221178D
3/17/23 21:02
3/15/23
RXDXPrometheus Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsMcKenna Mark C.CADOCB,P,CEOM.d732.900258355D
3/17/23 21:02
3/15/23
RXDXPrometheus Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsMcKenna Mark C.CADOCB,P,CEOS.d-2,904116.140-25-3155D
3/3/23 21:30
3/1/23
RXDXPrometheus Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsMcKenna Mark C.CADOCB,P,CEOM.dm423.700112655D
3/3/23 21:30
3/1/23
RXDXPrometheus Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsMcKenna Mark C.CADOCB,P,CEOS.dm-1,417125.140-11-1755D
2/17/23 21:31
2/15/23
RXDXPrometheus Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsMcKenna Mark C.CADOCB,P,CEOM.dm2163.3906455D
2/17/23 21:31
2/15/23
RXDXPrometheus Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsMcKenna Mark C.CADOCB,P,CEOS.dm-7,694120.820-64-5455D
1/19/23 20:39
1/17/23
RXDXPrometheus Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsMcKenna Mark C.CADOCB,P,CEOM.d732.900258355D
1/19/23 20:39
1/17/23
RXDXPrometheus Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsMcKenna Mark C.CADOCB,P,CEOS.d-2,975118.990-25-3155D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact